[Are rap genes anti-oncogenes?]

Area of Science:

• Molecular biology
• Cell signaling
• Oncogenesis

Context:

• Ras-related rap proteins (rap1 and rap2) exhibit significant structural and functional homology to ras oncogene products.
• The identical effector domain sequence between ras and rap proteins suggests potential competition for common effectors.
• The Krev-1 gene, isolated for its ability to revert ras-transformed cells, was identified as rap1A.

Purpose:

• To investigate the functional relationship between rap proteins and ras oncogenes.
• To determine if rap proteins can modulate the biological activity of ras proteins.
• To clarify the distinct roles of rap1 and rap2 in cellular transformation.

Summary:

• Rap1 protein competitively inhibits ras proteins' interaction with p120-GAP, a key ras effector, thereby antagonizing ras-mediated cellular transformation.
• Unlike rap1, rap2 protein does not affect the ras-p120-GAP interaction or influence ras-induced cellular proliferation and transformation.
• These findings indicate that rap genes are not anti-oncogenes, with rap1's antagonistic effect potentially due to experimental overexpression.

Impact:

• Differentiates the functional roles of rap1 and rap2 in the context of ras signaling pathways.
• Provides insights into potential therapeutic strategies targeting ras-driven cancers.
• Highlights the complexity of small G-protein signaling networks in cell growth and transformation.